Treatment Outcomes in Veterans with HPV-Positive Head and Neck Cancer
Conclusion HPV-positive HNSCC in the veteran population has a significantly improved prognosis relative to similarly staged patients with HPV-negative disease. This study demonstrates that the primary treatment modality – chemoradiation, radiation therapy, or surgery – does not impact overall survival among veterans with HPV-positive HNSCC.
Source: American Journal of Otolaryngology - Category: Endocrinology Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Carcinoma of Unknown Primary | Endocrinology | Head and Neck Cancer | HNSCC | Human Papillomavirus (HPV) | Laryngeal Cancer | Nasopharyngeal Cancer | Oral Cancer | Oral Cavity Cancer | Oropharyngeal Cancer | Radiation Therapy | Skin Cancer | Squamous Cell Carcinoma | Study